42 | Proteins (Proteins, Gene)FDA Link
03/2019
-
01/2002 |
28 | InterleukinsIBA
08/2014
-
08/2004 |
28 | adenovirus receptorIBA
01/2014
-
01/2002 |
25 | CytokinesIBA
02/2021
-
07/2003 |
18 | VaccinesIBA
08/2021
-
09/2002 |
15 | LuciferasesIBA
11/2013
-
11/2002 |
14 | Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA
06/2008
-
03/2002 |
12 | SurvivinIBA
01/2021
-
04/2004 |
11 | AntigensIBA
07/2018
-
01/2004 |
11 | LigandsIBA
01/2017
-
01/2002 |
11 | Biological ProductsIBA
01/2014
-
10/2003 |
11 | IntegrinsIBA
04/2011
-
03/2002 |
9 | Neutralizing AntibodiesIBA
01/2021
-
08/2002 |
8 | Pharmaceutical PreparationsIBA
03/2019
-
07/2004 |
7 | Interleukin-10 (Interleukin 10)IBA
05/2012
-
06/2008 |
7 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2010
-
03/2002 |
6 | AD 5IBA
01/2014
-
06/2010 |
6 | CeramidesIBA
09/2011
-
05/2009 |
6 | Antineoplastic Agents (Antineoplastics)IBA
02/2010
-
08/2002 |
6 | Thymidine KinaseIBA
12/2009
-
04/2002 |
6 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2009
-
10/2003 |
6 | ErbB Receptors (EGF Receptor)IBA
06/2008
-
01/2004 |
5 | Peptides (Polypeptides)IBA
01/2016
-
01/2002 |
5 | Phosphotransferases (Kinase)IBA
04/2010
-
03/2007 |
5 | Messenger RNA (mRNA)IBA
03/2008
-
03/2002 |
5 | Secretory Leukocyte Peptidase InhibitorIBA
02/2005
-
03/2003 |
4 | EpitopesIBA
02/2021
-
03/2005 |
4 | Carcinoembryonic AntigenIBA
01/2015
-
09/2002 |
4 | Neoplasm Antigens (Tumor Antigens)IBA
01/2012
-
05/2005 |
4 | Small Interfering RNA (siRNA)IBA
12/2010
-
11/2007 |
4 | Red Fluorescent ProteinIBA
10/2010
-
09/2009 |
4 | Therapeutic UsesIBA
12/2006
-
10/2002 |
4 | PolylysineIBA
11/2005
-
07/2002 |
4 | MidkineIBA
01/2005
-
04/2002 |
3 | OsteocalcinIBA
02/2021
-
02/2003 |
3 | EnzymesIBA
01/2021
-
12/2010 |
3 | AntibodiesIBA
10/2020
-
01/2015 |
3 | Cisplatin (Platino)FDA LinkGeneric
03/2019
-
08/2004 |
3 | ChemokinesIBA
01/2016
-
06/2004 |
3 | ElementsIBA
11/2013
-
10/2003 |
3 | CD40 Ligand (CD40L)IBA
09/2011
-
12/2005 |
3 | tanespimycin (17AAG)IBA
03/2011
-
01/2008 |
3 | Reactive Oxygen Species (Oxygen Radicals)IBA
11/2010
-
03/2007 |
3 | Capsid Proteins (Capsid Protein)IBA
04/2010
-
03/2003 |
3 | Ganciclovir (Cytovene)FDA LinkGeneric
01/2009
-
04/2002 |
3 | Firefly LuciferasesIBA
01/2009
-
11/2004 |
3 | CaspasesIBA
06/2008
-
08/2002 |
3 | Green Fluorescent ProteinsIBA
10/2006
-
05/2003 |
3 | Epidermal Growth Factor (EGF)IBA
11/2004
-
08/2003 |
2 | SteroidsIBA
01/2022
-
01/2004 |
2 | Viral RNAIBA
10/2020
-
05/2004 |
2 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017
-
11/2013 |
2 | MesothelinIBA
03/2016
-
06/2008 |
2 | GemcitabineFDA Link
04/2015
-
11/2009 |
2 | Somatostatin Receptors (Somatostatin Receptor)IBA
01/2014
-
02/2004 |
2 | NF-kappa B (NF-kB)IBA
11/2013
-
07/2003 |
2 | Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2013
-
06/2008 |
2 | enhanced green fluorescent proteinIBA
01/2013
-
08/2002 |
2 | Gentian Violet (Violet, Crystal)FDA Link
09/2012
-
03/2006 |
2 | Phosphates (Orthophosphate)IBA
09/2012
-
04/2009 |
2 | 1,1',6,6',7,7'- hexahydroxy- 3,3'- dimethyl- N5- (2- phenylpropyl)- N5'- (2- phenylpropyl)- 2,2'- binaphthyl- 5,5'- dicarboxamideIBA
05/2012
-
05/2011 |
2 | apogossypolIBA
05/2012
-
05/2011 |
2 | CalpainIBA
09/2011
-
05/2010 |